Q1 Earnings In Brief: Ironwood, Incyte, Arena, Ariad

Earnings season continues with reports from a swath of small biotechs. Ironwood reports higher Linzess sales, Incyte makes a European acquisition, Arena continues its decline, and Ariad explores strategic options.